The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn’s disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and costly disease. According to the CDC in the US, the incidence rate for Crohn’s disease was 3.1 to 14.6 cases per 100,000 people per year in 2015. The incidence rate of ulcerative colitis was 2.2 to 14.3 cases per 100,000 people per year in 2015. Moreover, the prevalence of IBD in Europe is increasing, according to the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA), there were 3.4 million cases of IBD in 2016. According to the WHO, the highest rates of IBD are found in, developed countries including the US and UK.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/ibd-inflammatory-bowel-disease-therapeutics-market

The global IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. For Crohn’s and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery.

A Full Report of Global Inflammatory Bowel Disease (IBD) Therapeutics Market is Available at:https://www.omrglobal.com/industry-reports/ibd-inflammatory-bowel-disease-therapeutics-market

The companies which are contributing to the growth of the global IBD therapeutics market include Abbott Laboratories, AbbVie Inc., Allergan, PLC Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Pfizer Inc., and others.

Market Segmentation

Global IBD Therapeutics Market by Disease Type

Ulcerative Colitis
Crohn’s Disease

Global IBD Therapeutics Market by Treatment Type

Surgery
Anti- Inflammatory Drug Administration
Steroids
Immunosuppressant
Biological Drugs
Amino salicylates
Others

Regional Analysis

North America

United States
Canada

Europe

UK
Germany
France
Italy
Spain
Rest of Europe

Asia-Pacific

China
India
Japan
Rest of Asia-Pacific

Rest of the World

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ibd-inflammatory-bowel-disease-therapeutics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404